MKMeri Kocharyan

Meri Kocharyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meri Kocharyan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In Silico Targeting of PI3K/Akt Signaling by Polyphenols from Hypericum alpestre and Rumex obtusifolius: A Molecular Docking Study

    by Meri Kocharyan, Mikayel Ginovyan, Smbat Gevorgyan, Nikolay Avtandilyan

    The PI3K/Akt signaling pathway is a central regulator of cancer cell survival, proliferation, angiogenesis, and therapeutic resistance. Polyphenolic compounds from medicinal plants have gained attention as potential multi-targeted inhibitors of this pathway. This study explores the binding interactions of major polyphenols from Hypericum alpestre (HA) and Rumex obtusifolius (RO) with PI3K and Akt using in silico approaches. Protein structures of PI3K (PDB ID: 6AUD) and Akt (PDB ID: 2JDO) were retrieved from the RCSB Protein Data Bank. The structures were pre-processed in PyMOL by removing water molecules and co-crystallized ligands. Key phytochemicals from HA (chrysoeriol glucuronide, pseudohypericin) and RO (emodin, endocrocin, luteolin, quercetin) were docked using AutoDock Vina with an exhaustiveness value of 8. Binding affinities, hydrogen bonding, and hydrophobic interactions were analysed. SwissADME was used to evaluate pharmacokinetic properties. Chrysoeriol glucuronide and pseudohypericin showed strong interactions with PI3K and Akt, including hydrogen bonds with Ala805, Ser806, and Glu230. Among RO-derived compounds, emodin, endocrocin, luteolin, and quercetin demonstrated high affinity for both targets. Quercetin formed four hydrogen bonds with Akt and two with PI3K, while emodin interacted with Tyr867, Asp964, and Lys160. These compounds also displayed favourable drug-like properties, meeting Lipinski’s Rule of Five criteria and showing potential for oral bioavailability. The molecular docking results indicate that selected polyphenols from HA and RO can stably bind to key residues of PI3K and Akt, supporting their potential as natural inhibitors of this signaling axis. Their pharmacokinetic profiles and interaction patterns suggest suitability for further development in targeted anticancer therapy.

  • Open Access

    Elucidating the Impact of Hypericum alpestre Extract and L-NAME on the PI3K/Akt Signaling Pathway in A549 Lung Adenocarcinoma Cells

    by Hayarpi Javrushyan, Mikayel Ginovyan, Gayane Petrosyan, Mery Qocharyan, Tigran Harutyunyan, Smbat Gevorgyan, Zaruhi Karabekian, Alina Maloyan, Nikolay Avtandilyan

    Plants within the Hypericaceae family have been traditionally used for their medicinal properties, showcasing a wide range of effects such as antibacterial, antiviral, and antioxidant qualities. Hypericum alpestre (HA) extracts have exhibited significant cytotoxicity against various cancer cell lines. The phenolic compounds found in HA extracts have attracted attention for their potential in cancer prevention. L-NAME, known for its ability to inhibit nitric oxide synthase (NOS) activity, has emerged as a promising approach in cancer therapy. However, the precise molecular mechanisms underlying the anticancer effects of HA and L-NAME remain unclear. This study aims to clarify the impact of HA and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma cells, with a specific focus on TNFa/COX-2 and VEGFa/MMP-2 pathways. In silico analysis, they identified the compounds with the highest affinity for PI3K/Akt, a finding validated by subsequent in vitro experiments. Furthermore, the combination of herbs and L-NAME exhibited superior efficacy compared to the herb and 5-FU combination, as evidenced by the promotion of apoptosis. Both the herb alone and the combination of the herb with L-NAME demonstrated inhibitory effects on the TNFa/COX-2 and VEGFa/MMP-2 pathways. This therapeutic approach is hypothesized to operate through the PI3k/Akt cell signaling pathway. A better understanding of the interaction between HA polyphenols and PI3K/Akt signaling could pave the way for novel therapeutic strategies against cancer, including drug-resistant tumors.